Aclarion Inc (ACON)

Jun 11, 2025

Contrasting Aclarion (NASDAQ:ACON) and Aeon Global Health (OTCMKTS:AGHC) - Defense World

Jun 11, 2025

Jun 10, 2025

Aclarion Adds UHealth, University of Miami Miller School of Medicine as CLARITY Trial Site - Ortho Spine News

Jun 10, 2025

Jun 10, 2025

Aclarion (ACON) Expands CLARITY Trial with University of Miami H - GuruFocus

Jun 10, 2025

Jun 10, 2025

Aclarion Inc. Announces UHealth and University of Miami as New Site for CLARITY Clinical Trial Evaluating Nociscan for Chronic Low Back Pain - Nasdaq

Jun 10, 2025

May 31, 2025

Aclarion (NASDAQ:ACON) Upgraded by Wall Street Zen to Hold Rating - Defense World

May 31, 2025

May 30, 2025

Aclarion stock price target cut to $20 at Ascendiant Capital - Investing.com Australia

May 30, 2025

May 30, 2025

Aclarion stock price target cut to $20 at Ascendiant Capital By Investing.com - Investing.com India

May 30, 2025

May 29, 2025

Aclarion, Inc. (NASDAQ:ACON) Sees Large Drop in Short Interest - Defense World

May 29, 2025

May 22, 2025

Aclarion (NASDAQ:ACON) Trading Down 1.2% – Here’s Why - Defense World

May 22, 2025

May 20, 2025

Aclarion Announces Addition of Keck Medical Center of USC as CLARITY Trial Site - Ortho Spine News

May 20, 2025

May 20, 2025

USC Medical Center Joins Groundbreaking AI Trial to Revolutionize Chronic Back Pain Diagnosis - Stock Titan

May 20, 2025

May 15, 2025

Aclarion, Inc. SEC 10-Q Report - TradingView

May 15, 2025

May 13, 2025

Aclarion (ACON) Expands CLARITY Trial with Texas Back Institute - GuruFocus

May 13, 2025

May 12, 2025

Aclarion Announces Texas Back Institute as New CLARITY Trial Site - Ortho Spine News

May 12, 2025

May 12, 2025

Aclarion announces Texas Back Insitute as new CLARITY trial site - TipRanks

May 12, 2025

May 12, 2025

Aclarion Inc. Partners with Texas Back Institute for CLARITY Clinical Trial to Enhance Chronic Low Back Pain Treatment - Nasdaq

May 12, 2025

May 12, 2025

History Says Now Is the Time to Buy Nvidia Stock - The Globe and Mail

May 12, 2025

May 05, 2025

Aclarion Welcomes Advocate Health as CLARITY Trial Site - Ortho Spine News

May 05, 2025

May 05, 2025

Major Breakthrough: Advocate Health to Test AI-Powered Spine Pain Diagnostic in 300-Patient Trial - Stock Titan

May 05, 2025

May 03, 2025

Aclarion secures funding for pivotal CLARITY trial - MSN

May 03, 2025

Apr 29, 2025

Aclarion Announces Commercial Agreement with Spine Institute of Louisiana - Ortho Spine News

Apr 29, 2025

Apr 29, 2025

Aclarion (ACON) Partners with Louisiana Spine Institute to Expan - GuruFocus

Apr 29, 2025

Apr 29, 2025

Aclarion announces agreement with the Spine Institute of Louisiana - TipRanks

Apr 29, 2025

Apr 29, 2025

Aclarion Expands Nociscan Access with Commercial Agreement at Spine Institute of Louisiana - Nasdaq

Apr 29, 2025

Apr 29, 2025

Revolutionary Spine Pain Technology Nociscan Achieves 97% Success Rate, Expands to 17 Medical Centers - Stock Titan

Apr 29, 2025

Apr 28, 2025

Aclarion stock hits 52-week low at $7.25 amid steep annual decline By Investing.com - Investing.com South Africa

Apr 28, 2025

Apr 28, 2025

Aclarion stock hits 52-week low at $7.25 amid steep annual decline - Investing.com

Apr 28, 2025

Apr 27, 2025

Aclarion, Inc. (NASDAQ:ACON) Short Interest Update - Defense World

Apr 27, 2025

Apr 25, 2025

Aclarion Inc Files For Mixed Shelf Of Up To $150 MlnSEC Filing - marketscreener.com

Apr 25, 2025

Apr 23, 2025

Aclarion Releases Updated Investor Presentation at Showcase - TipRanks

Apr 23, 2025

Apr 23, 2025

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet MicroCap Showcase: VEGAS 2025 - The Manila Times

Apr 23, 2025

Apr 23, 2025

Aclarion, Inc. to Present at Planet MicroCap Showcase: VEGAS 2025 on Chronic Low Back Pain Solutions - Nasdaq

Apr 23, 2025

Apr 23, 2025

Aclarion Releases Updated Investor Presentation in Connection with Appearance at Planet ... - Bluefield Daily Telegraph

Apr 23, 2025

Apr 23, 2025

Aclarion's Revolutionary AI Approach to Chronic Back Pain: New Investor Strategy Revealed at MicroCap Vegas - Stock Titan

Apr 23, 2025

Apr 22, 2025

3 Reasons to Buy Amazon Stock Like There's No Tomorrow - The Globe and Mail

Apr 22, 2025

Apr 21, 2025

Aclarion Announces Publication of Seminal Nociscan Cost-Effectiveness Analysis - Ortho Spine News

Apr 21, 2025

Apr 21, 2025

Aclarion's Nociscan Demonstrates Cost-Effectiveness and Improved Surgical Success Compared to Provocative Discography - Nasdaq

Apr 21, 2025

Apr 21, 2025

New Research: AI-Powered Spine Technology Cuts Patient Costs by $1,712, Boosts Surgery Success 10% - Stock Titan

Apr 21, 2025

Apr 12, 2025

NOCISCAN touted as lumbar pain diagnostic advance - MSN

Apr 12, 2025

Apr 11, 2025

12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga

Apr 11, 2025

Apr 09, 2025

Aclarion to Present at the Planet MicroCap Showcase: VEGAS in Partnership with MicroCapClub - The Manila Times

Apr 09, 2025

Apr 09, 2025

Aclarion, Inc. SEC 10-K Report - TradingView

Apr 09, 2025

Apr 08, 2025

Aclarion stock hits 52-week low at $9.68 amid steep annual decline - Investing.com Canada

Apr 08, 2025

Apr 07, 2025

Aclarion stock hits 52-week low at $9.68 amid steep annual decline By Investing.com - Investing.com South Africa

Apr 07, 2025